Tissue Immune Profile: A Tool to Predict Response to Neoadjuvant Therapy in Triple Negative Breast Cancer.
Cerbelli B, Scagnoli S, Mezi S, De Luca A, Pisegna S, Amabile MI, Roberto M, Fortunato L, Costarelli L, Pernazza A, Strigari L, Della Rocca C, Marchetti P, d'Amati G, Botticelli A.
Cerbelli B, et al. Among authors: pernazza a.
Cancers (Basel). 2020 Sep 16;12(9):2648. doi: 10.3390/cancers12092648.
Cancers (Basel). 2020.
PMID: 32947953
Free PMC article.